Cite
HARVARD Citation
Wang, X. et al. (2021). A first‐in‐human, randomized, double‐blind, single‐ and multiple‐dose, phase I study of recombinant human thymosin β4 in healthy Chinese volunteers. Journal of cellular and molecular medicine. 25 (17), pp. 8222-8228. [Online].